The Association for Molecular Pathology Adds Late-Breaking Session on Laboratory Developed Procedures Oversight and Regulation to the 2014 Annual Meeting Program

AMP's late-breaking session, titled, "Framework for Oversight of LDTs: A Conversation with FDA" is scheduled for Thursday, November 13, 2014 at 1:00pm EST. Immediately following, AMP will host a press conference, convening a panel of molecular pathology clinical professionals, from a variety of clinical laboratory settings, to appropriately frame the discussion regarding clinical care and appropriate regulation.